Leerink Partnrs Has Pessimistic Outlook of ACHC Q1 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities researchers at Leerink Partnrs reduced their Q1 2025 earnings per share (EPS) estimates for shares of Acadia Healthcare in a note issued to investors on Thursday, December 12th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.72 per share for the quarter, down from their previous estimate of $0.76. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q2 2025 earnings at $0.87 EPS, Q3 2025 earnings at $0.87 EPS, Q4 2025 earnings at $0.80 EPS, FY2025 earnings at $3.26 EPS and FY2026 earnings at $3.95 EPS.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same period in the prior year, the firm earned $0.91 earnings per share. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year.

A number of other research firms have also weighed in on ACHC. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. KeyCorp initiated coverage on Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating on the stock. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, November 22nd. Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a report on Tuesday, December 10th. Finally, Barclays reduced their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 22nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $75.44.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $39.64 on Monday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The firm has a market cap of $3.68 billion, a PE ratio of 13.00, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company’s 50 day moving average is $44.78 and its two-hundred day moving average is $61.40.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Wellington Management Group LLP grew its holdings in shares of Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after purchasing an additional 1,266,384 shares during the last quarter. William Blair Investment Management LLC boosted its position in shares of Acadia Healthcare by 20.7% in the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after purchasing an additional 604,070 shares during the period. State Street Corp grew its stake in Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after buying an additional 95,613 shares during the last quarter. Point72 Asset Management L.P. increased its position in Acadia Healthcare by 0.5% during the third quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after buying an additional 12,470 shares during the period. Finally, Geode Capital Management LLC lifted its stake in Acadia Healthcare by 0.9% in the third quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after buying an additional 14,197 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.